Management of cardiogenic shock during cardiac surgery with long-term use of percutaneous cardiopulmonary support: A case report.
10.4097/kjae.2008.55.5.625
- Author:
Jong Chan KIM
1
;
Jae Kwang SHIM
;
Jiwon AN
;
Jae Woo LEE
;
Dae Hee KIM
;
Young Lan KWAK
Author Information
1. Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine, Seoul, Korea. ylkwak@yuhs.ac
- Publication Type:Case Report
- Keywords:
cardiogenic shock;
percutaneous cardiopulmonary support (PCPS);
surgical anterior ventricular endocardial restoration (SAVER)
- MeSH:
Coronary Artery Bypass;
Extracorporeal Circulation;
Hemodynamics;
Heparin;
Humans;
Prognosis;
Shock, Cardiogenic;
Thoracic Surgery
- From:Korean Journal of Anesthesiology
2008;55(5):625-628
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Percutaneous cardiopulmonary support (PCPS) provides hemodynamic and pulmonary support simultaneously and is increasingly used in medical practice. However, the presence of extracorporeal circulation and the use of heparin means it is not free of side effects, and use of PCPS for longer than 96 h is associated with poor prognosis. Therefore, along with the decision of when to apply or discontinue PCPS, an integrated team approach between the surgeon and the anesthesiologist to prevent and/ or manage PCPS-related complications is of paramount importance when the patient's physical status mandates prolonged use of PCPS. We hereby report 2 cases addressing successful management of postoperative cardiogenic shock, refractory to pharmacologic support, with early and prolonged application of PCPS in patients who underwent surgical anterior ventricular endocardial restoration and coronary artery bypass surgery.
